•Factor VIII inhibitor can be acquired in gynecologic and other malignancies.•The disorder can develop along any timeline of malignancy diagnosis.•Common presentation is uncontrolled bleeding not managed by common interventions.•Treatment requires hemostatic control and an immunosuppressive regimen.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422097 | PMC |
http://dx.doi.org/10.1016/j.gore.2023.101217 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!